{
    "2019-03-15": [
        [
            {
                "time": "2018-03-15",
                "original_text": "格隆汇港股聚焦(3.15)︱福耀玻璃2018年净利润升30.87%至41.2亿元 拟每10股派7.5元",
                "features": {
                    "keywords": [
                        "福耀玻璃",
                        "净利润",
                        "增长",
                        "分红"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "汽车"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "渤海证券医药行业二季度投资策略报告：着眼精品，强者恒强",
                "features": {
                    "keywords": [
                        "渤海证券",
                        "医药行业",
                        "投资策略",
                        "强者恒强"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医疗保健：科创板利好科技创新型企业 荐15股",
                "features": {
                    "keywords": [
                        "医疗保健",
                        "科创板",
                        "科技创新",
                        "推荐股票"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗保健",
                        "科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "[推荐评级] 医药生物-医保目录调整将至 继续深化“腾笼换鸟”",
                "features": {
                    "keywords": [
                        "医药生物",
                        "医保目录",
                        "调整",
                        "腾笼换鸟"
                    ],
                    "sentiment_score": 0.65,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "复星医药旗下生物类似药子公司复宏汉霖取得药品GMP证书",
                "features": {
                    "keywords": [
                        "复星医药",
                        "生物类似药",
                        "复宏汉霖",
                        "GMP证书"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}